baber/WOPTO huggingface dataset:
Patent AU-5441199-A (AU)
Title: Oral vaccine compositions
Inventor: BRAYDEN DAVID JAMES
IPC: A61P31/04
Filed: 1999-08-31
Abstract: Oral vaccine formulations are disclosed having microparticles sized such that at least 50% of the microparticles are less than 5 µm, preferably less than 3 µm, the microparticles containing antigen entrapped or encapsulated, such as by a solvent evaporation method, by a biodegradable polymer, such as poly (D,L-lactide-co-glycolide). Additionally, oral vaccine formulations are disclosed having nanoparticles sized such that at least 50% of the microparticles are less than 600nm, preferably less than 500nm, the nanoparticles containing antigen entrapped or encapsulated, such as by a coacervation method, by a biodegradable polymer, such as poly (D,L-lactide-co-glycolide). Protective vaccine formulations containing the  B. pertussis  antigens PTd or a combination of PTd and FHA are provided.
Patent AU-5530294-A (AU)
Title: A right-angle gear reduction unit
Inventor: CASAROTTO GIORGIO
IPC: F16H1/20
Filed: 1993-10-28
Abstract: In a right-angle gear reduction unit, a drive input shaft (3) is arranged to protrude out of the reduction unit case (2) with both of its opposite axial ends (3a, b), thereby one of said ends can be used for coupling to following reduction units and/or auxialiary devices.
Patent AU-5546301-A (AU)
Title: Preparation of injectable suspensions having improved injectability
Inventor: RAMSTACK J MICHAEL
IPC: A61K9/00
Filed: 2001-04-19
Abstract: Injectable compositions having improved injectability. The injectable compositions include microparticles in an aqueous injection vehicle having a viscosity of at least 20 cp at 20 °C. The increased viscosity of the injection vehicle that constitutes the fluid phase of the suspension significantly reduces  in vivo  injectability failures. The injectable compositions can be made by mixing dry microparticles with an aqueous injection vehicle to form a suspension, and then mixing the suspension with a viscosity enhancing agent to increase viscosity of the fluid phase of the suspension to the desired level for improved injectability.
Patent AU-5592601-A (AU)
Title: Encryption processing for streaming media
Inventor: RAIKE WILLIAM MICHAEL
IPC: H04L9/08
Filed: 2001-07-25
Abstract: A method for securing transmission of streaming media by encrypting each packet (25) in the stream with a packet key (21) using a fast encryption algorithm (6). The packet key (21) is a hash (5) of the packet tag value (24) and a closed key (22) which is unique for each stream. The closed key (22) is itself encrypted by the sender and passed to the recipient using a public key encryption system (2, 3, 11, 12). The encrypted closed key (23) may conveniently be inserted (27) into the stream header. All of the packets in the stream (29) are encrypted, but only the data pay load (25) of each packet is encrypted. It is computationally infeasible, without knowing the recipient's private key (11) to calculate the closed key (22) based upon knowledge of publicly accessible information such as the recipient's public key (2), the open key (23), the encrypted stream data (29) or the packet tag values (24). <IMAGE>
Patent AU-5635394-A (AU)
Title: Antiviral pyrimidine nucleosides
Inventor: WALKER RICHARD
IPC: A61K31/7028
Filed: 1994-02-23
Abstract: Pyrimidine 4 min -thionucleosides of the formula I <CHEM> wherein Y is hydroxy or amino, and X is chloro, bromo, iodo, trifluoromethyl, C2-6 alkyl, C2-6 alkenyl, C2-6 haloalkenyl or C2-6 alkynyl and physiologically functional derivatives thereof. These compounds have utility as anti-viral agents.
Patent AU-5786690-A (AU)
Title: Process for purifying tryptophan
Inventor: KONO YOSHITSUGU
IPC: C07D209/20
Filed: 1990-06-26
Abstract: A process for purifying tryptophan is disclosed. In the process of the present invention, tryptophan is recrystallized in water-containing acetic acid. By the process of the present invention, tryptophan with high purity may be obtained with high yield without condensation or neutralization.
Patent AU-5813900-A (AU)
Title: Production of olefins
Inventor: DATH JEAN-PIERRE
IPC: C10G11/00
Filed: 2000-06-08
Abstract: A process for cracking an olefin-rich hydrocarbon feedstock which is selective towards propylene in the effluent, the process comprising contacting a hydrocarbon feedstock containing one or more olefinic components of C4 or greater with a crystalline silicate catalyst to produce an effluent having a second composition of one or more olefinic components of C3 or greater, the feedstock and the effluent having substantially the same olefin content by weight therein characterised in that ethylene is added to the feedstock before the feedstock contacts the catalyst.
Patent AU-5828300-A (AU)
Title: Solvent-free, room temperature curing reactive systems and the use thereof in the production of adhesives, sealing agents, casting compounds, molded articles orcoatings
Inventor: TILLACK JORG
IPC: C08G18/20
Filed: 2000-07-17
Abstract: The present invention relates to novel solventless reactive systems curable at room temperature, based on blocked polyisocyanates, primary amines, compounds with oxirane groups, and 2,3-dimethyl-3,4,5,6-tetrahydropyrimidine, and to processes for the preparation of these solventless reactive systems curable at room temperature.
Patent AU-5910586-A (AU)
Title: Circuit arrangement for feeding an electric load from a solar generator
Inventor: MIETH GUNTHER
IPC: G05F1/67
Filed: 1986-06-19
Abstract: A circuit arrangement for feeding an electrical load, solar generator provides that the current output by the solar generator has a prescribed ratio to the measured value which is a measure for the short-circuit current of the solar generator. Such a circuit arrangement has an optimally-high efficiency. This is achieved with comparatively low expense in that the short-circuit current of the solar generator is measured pulse-wise. The circuit arrangement can be employed with particular advantage for charging batteries in solar systems.
Patent AU-5934398-A (AU)
Title: Methods for treating allergic disorders using (-) cetirizine
Inventor: GRAY NANCY M
IPC: A61K31/495
Filed: 1998-03-17
Abstract: Methods and compositions are disclosed utilizing optically pure (-) cetirizine for the treatment of seasonal and perennial allergic rhinitis in humans while avoiding the concomitant liability of adverse effects associated with the racemic mixture of cetirizine. The optically pure (-) isomer is also useful for the treatment of allergic asthma and chronic and physical urticaria. (-) Cetirizine is an inhibitor of eosinophil chemotaxis and is therefore useful in the treatment of other conditions related to eosinophilia such as allergic asthma, seasonal allergic rhinitis, atopic dermatitis, some parasitic diseases, some chronic obstructive lung diseases and certain gastrointestinal and genitourinary disorders.
Patent AU-5955598-A (AU)
Title: Semiconductor device with selectively diffused regions
Inventor: HORZEL JORG
IPC: H01L31/04
Filed: 1997-12-22
Abstract: The present invention describes a method of manufacturing a semiconductor device, comprising a semiconducting substrate (2) in the shape of a slice, the method comprising the steps of:   step 1) selectively applying a pattern of a solids-based dopant source to a first major surface of said semiconducting substrate (2);   step 2) diffusing the dopant atoms from said solids-based dopant source into said substrate (2) by a controlled heat treatment step in a gaseous environment surrounding said semi-conducting substrate (2), the dopant from said solids-based dopant source diffusing directly into said substrate (2) to form a first diffusion region (12) in said substrate immediately beneath said pattern of said solids-based dopant source and, at the same time, diffusing said dopant from said solids-based dopant source indirectly via said gaseous environment into said substrate (2) to form a second diffusion region (15) in at least some areas of said substrate (2) not covered by said pattern; and step 3) forming a metal contact pattern (20) substantially in alignment with said first diffusion region (12) without having etched said second diffusion region (15) substantially.   The semiconductor device in accordance with the present invention made by the above method may have a monotonically decreasing resistance value between the first and second diffusion regions (12, 15). <IMAGE>
Patent AU-5997900-A (AU)
Title: Data classifier output interpretation
Inventor: BUTCHART KATE
IPC: G06F15/18
Filed: 2000-07-12
Abstract: A method, apparatus, and computer software are provided whereby to associate a readily user-interpretable reason with an output of a supervised training data classifier. Reasons are associated with one or more members of a sequence of training vectors and subsequently associated, in operation, with a given classifier input by comparing the classifier input vector with training sequence vectors. A measure of confidence in the selected reasons is derived by comparing the classifier input vector with the corresponding training inputs with which the selected reasons were associated and calculating a measure of their closeness.
Patent AU-6240090-A (AU)
Title: Method and apparatus for preparing nitride products
IPC: C04B35/58
Filed: 1990-09-12
Abstract: A method and apparatus are provided for producing a product comprising a nitride compound, such as for example silicon nitride. A reactor is provided which has a chamber defined therein which is divided into a combustion zone and a reaction zone. A combustible mixture is injected into the combustion zone and accordingly combusted to form hot combustion products. At least one reactant (i.e. silane) is injected at the boundary between the zones so as to be carried into the reaction zone by the combustion products and react to form raw product comprising the nitride compound. The raw product can be purified by subsequent processing to remove oxygen and convert by-products to the desired nitride compound. The product of the invention has a low level of impurties and is made up of primarily submicron, highly uniform particles. This makes the product particularly useful for fabrication of sintered ceramic parts.
Patent AU-6307494-A (AU)
Title: Recombinant poxvirus and streptococcal M protein vaccine
Inventor: FISCHETTI VINCENT A
IPC: C12N15/63
Filed: 1994-05-12
Abstract: Viruses of the family poxviridae such as vaccinia or fowlpox viruses are modified to contain a gene which expresses a protein corresponding to the conserved exposed region of the M6 protein. The modified products are useful as vaccines against streptococcal infection.
Patent AU-6570000-A (AU)
Title: Method for preparing highly stabilised hydroxylamine solutions
Inventor: WATZENBERGER OTTO
IPC: B01J41/04
Filed: 2000-08-03
Abstract: The present invention relates to a process for the preparation of high-purity, stabilized hydroxylamine solutions in which an aqueous hydroxylamine starting solution is treated with an anion exchanger which has been pre-loaded with a hydroxylamine stabilizer in order to remove anions.
Patent AU-6742196-A (AU)
Title: Pesticidal indazole derivatives
Inventor: FAROOQ SALEEM
IPC: A01N43/56
Filed: 1996-08-05
Abstract: PCT No. PCT/EP96/03452 Sec. 371 Date Feb. 17, 1998 Sec. 102(e) Date Feb. 17, 1998 PCT Filed Aug. 5, 1996 PCT Pub. No. WO97/07103 PCT Pub. Date Feb. 27, 1997Compounds of formula (1), wherein X, Y, Z R2, R3, R4, R5, R7, R9 and n are as defined in claim 1 and, where appropriate, E/Z isomers, mixtures of E/Z isomers and/or tautomers thereof, in each case in free form or in agrochemically suitable salt form, can be used as agrochemical active ingredients and can be prepared in a manner known per se.
Patent AU-6833796-A (AU)
Title: Regulation of intracellular glucocorticoid concentrations
Inventor: WALKER BRIAN ROBERT
IPC: A61K31/56
Filed: 1996-08-28
Abstract: The interconversion of inactive 11-keto steroids with their active 11 beta -hydroxy equivalents can be controlled by the use of inhibitors of the 11 beta -reductase enzyme, such as carbenoxolone (3 beta -(3-carboxypropionyloxy)-11-oxo-olean-2-en30-oic acid). Such inhibitors may be put to a number of therapeutic uses in humans and animals, for instance to inhibit hepatic gluconeogenesis, to lower intracellular cortisol concentration, to increase insulin sensitivity in adipose tissue and muscle, and to prevent or reduce neuronal loss/cognitive impaiment due to glucocorticoid potentiated neurotoxicity or neural dysfunction or damage.
Patent AU-6846798-A (AU)
Title: Method of nucleic acid sequencing
Inventor: KAWASHIMA ERIC H
IPC: C12Q1/68
Filed: 1998-04-01
Abstract: Different nucleic acid molecules present at different locations can be sequenced in parallel. Primers that are annealed to the nucleic acid molecules can be provided. Each location can then be provided with a nucleic acid polymerase and a nucleotide. It can then be determined whether or not the nucleotide has been used in primer extension and the process can be repeated. As an alternative to using primers, a nick in the double stranded nucleic acid molecule can provide a 3'-OH group for chain extension.
Patent AU-7112494-A (AU)
Title: Medium for long-term proliferation and development of cells
Inventor: PONTING IAN L O
IPC: C12N5/00
Filed: 1994-06-17
Abstract: A serum-free or serum-depleted medium for the short- and long-term proliferation and development of cells, particularly hematopoietic cells and bone marrow stromal cells, the medium comprising cell proliferation and development effective amounts of: a standard culture medium such as Iscove's modified Dulbecco's medium; serum albumin; transferrin; a source of lipids and fatty acids; cholesterol; a reducing agent; pyruvate; a glucocorticoid (when the cells to be cultured are hematopoietic cells); nucleosides for synthesis of DNA and RNA; growth factors that stimulate the proliferation and development of stromal cells and cells from a variety of tissues or organs, such as epidermal growth factor, fibroblast growth factor, platelet derived growth factor, and insulin; and extracellular matrix materials, such as collagen, fibronectin, and laminin.
Patent AU-7134091-A (AU)
Title: N-cycloalkylalkylamines, their process of preparation, their use as a medicament and their synthesis intermediates
Inventor: AUBARD GILBERT
IPC: C07D/
Filed: 1991-02-25
Abstract: N-Cycloalkylalkylamines of general formula (I) <IMAGE>  in which:   R1 is a furyl or thienyl radical or is a phenyl radical, provided that Q denotes a 1,2-cyclopropanediyl group,   R2 is lower alkyl,   R3 is hydrogen or lower alkyl,   m has the value 1 or 2,   R4 is cycloalkyl -CH(CH2)n, in which n is an integer from 2 to 5,   R5 is optionally substituted phenyl or thienyl, Q is 1,2-ethylenediyl or 1,2-cyclopropanediyl, and their addition salts with acids.   These amines are psychotropic medications and are also useful in gastroenterology.
Patent AU-7185600-A (AU)
Title: A pharmaceutical preparation for treating blood coagulation disorders
Inventor: TURECEK PETER
IPC: A61K38/00
Filed: 2000-11-24
Abstract: The following are claimed: (1) a pharmaceutical composition for treating blood clotting disorders, containing ≥ 2 clotting factors that are components of a pro-thrombinase or pro-pro-thrombinase and are free of phospholipids; (2) a composition containing purified prothrombin as the sole active ingredient; (3) a composition for treating clotting disorders, containing biologically active purified prothrombin; (4) a complex consisting of prothrombin, factor Xa and optionally factor V or Va; (5) a complex consisting of prothrombin and factor V or Va; (6) a complex consisting of factor X and factor V or Va; (7) a preparation containing the complex of (4), (5) or (6) and calcium ions; (8) a process for preparing a purified pharmaceutical prothrombin composition, comprising subjecting a prothrombin complex concentrate to chromatographic purification and converting the fraction containing prothrombin into a pharmaceutical preparation; (9) a prothrombin composition obtainable by the process of (8) which is free of thromboembolic side effects at a dose of ≥ 150 U prothrombin/kg, as expressed by a score of ≤ 3 in the Wessler thrombosis model, and which in freeze-dried form can be reconstituted to a clear solution with an activity of ≥ 10 U prothrombin/ml in a dissolution time of ≤ 1 minute, and (10) use of purified pro-thrombinase factors to produce a pharmaceutical preparation for establishing supra-normal prothrombin concentrations in the blood of a patient.
Patent AU-7336994-A (AU)
Title: Apparatus for countercurrent multiphase liquid separation
Inventor: COLLIER CHARLES FORREST
IPC: B01D11/04
Filed: 1994-07-26
Abstract: A reusable apparatus for multiphase, multistage countercurrent liquid separation is presented. The apparatus is particular useful in progressive multistage separation of target microorganisms from background organisms and materials with precise transfer, air exclusion, homogeneous mixing, isolation from the ambient atmosphere, in the absence of valves and at ow cost. The structure has at least one chamber in which a piston-like sliding bottom is sealingly moved or braked and includes internal structure for mixing, preferably a magnetic-stainless steel ball which can be reciprocated from the outside to mix the liquid contents. Motion of the bottom is limited by stops. A number of ways to actuate the apparatus are taught.
Patent AU-7487198-A (AU)
Title: Cracking furnace with radiant heating tubes
Inventor: BREWER JOHN R
IPC: F28D7/06
Filed: 1998-05-11
Abstract: The present invention provides a furnace and process that relies on a multiplicity of radiant heating tubes, each in the form of a U-shaped coil, that are mounted within a furnace firebox such that an inlet leg of any one of the plural tubes is immediately adjacent and spaced apart from an outlet leg of another one of the plural tubes within the firebox of a thermal cracking furnace. This spacial pairing of an inlet leg of one tube with an outlet leg of another tube of the plural radiant heating tubes of the cracking furnace maximizes utilization of the available radiant heat within the firebox of a thermal cracking furnace while reducing the likelihood of localized hot spotting that could produce coke-tar plugging of a tube.
Patent AU-7638796-A (AU)
Title: Propylene composition, process for preparing the same, polypropylene composition, and molded articles
Inventor: OKAYAMA CHIKASHI
IPC: B32B27/32
Filed: 1996-11-22
Abstract: A polypropylene composition for the production of various molded articles which are excellent in moldability, mold shrinkage factor on molding, rigidity, flexibility, impact resistance, in particular low-temperature impact resistance, transparency, gloss, stress-whitening resistance, and the balance thereof; various molded articles having the above properties; a propylene composition which is suitable for a base resin for the polypropylene composition; and a process for the production thereof. The propylene composition comprises a propylene homopolymer and a propylene-ethylene copolymer, the intrinsic viscosity of the copolymer (Ä eta ÜRC) is in the range of 1.7 to 2.8 dl/g, the intrinsic viscosity ratio of the homopolymer to the copolymer (Ä eta ÜRC/Ä eta ÜPP) is in the range of 0.7 to 1.2 and a product Ä(WPP/WRC) x (Ä eta ÜRC/Ä eta ÜPP)Ü of the weight ratio (WPP/WRC) of the homopolymer to the copolymer and the intrinsic viscosity ratio thereof is in the range of 1.0 to 3.0.
Patent AU-7688894-A (AU)
Title: Fire retardant agents suitable for plastics
Inventor: LOPEZ FIDENCIANO
IPC: C09K21/10
Filed: 1994-09-14
Abstract: PCT No. PCT/AU94/00545 Sec. 371 Date Oct. 1, 1996 Sec. 102(e) Date Oct. 1, 1996 PCT Filed Sep. 14, 1994 PCT Pub. No. WO95/07947 PCT Pub. Date Mar. 23, 1995A fire retardant agent to be incorporated in a plastic, especially polyurethane foam which functions as a foaming agent and comprises a mixture of soluble ammonium salts selected from the group consisting of ammonium monophosphate, ammonium diphosphate and an ammonium halide; and urea. Processes and apparatus for the production of a polyurethane foam are also described.
Patent AU-7883598-A (AU)
Title: Refractory material consisting of beta alumina
Inventor: ZANOLI ALAIN PAUL BERNARD
IPC: C04B35/107
Filed: 1998-08-07
Abstract: A novel fused  beta  alumina refractory material has the molar composition 11.25-15.45% Na2O, Li2O and/or K2O (the Na2O content being ≥ 9.3%), 0-2.97% SiO2, 81.38-88.75% Al2O3 and  NOTGREATER 0.2% impurities, ≥ 98% of the crystalline phase content comprising beta  alumina. Preferably, the material has the composition (by wt.) 7.25-10 (preferably 7.4-8.5)% Na2O, 0-1.85 (preferably 0.7-1.45)% SiO2, 87.95-92.75 (preferably 89.85-91.9)% Al2O3 and  NOTGREATER 0.2% impurities.
Patent AU-7884091-A (AU)
Title: Sound association and learning system
Inventor: KIMBALL DAN VANCE
IPC: G09B5/06
Filed: 1991-05-08
Abstract: A learning and identification support system for birders and such comprising, a media having a plurality of visually recognizable bird pictures thereon associated with respective ones of a plurality of birds to have birdsong associated therewith. A plurality of scannable barcodes are disposed on the media and associated with respective ones of the bird pictures. Each of the plurality of scannable barcodes comprises a unique index indicating the one of the bird pictures with which it is associated. A barcode scanner is used for scanning individual selected ones of the barcodes to obtain an electrical signal at an output thereof containing the unique index. There is a Compact Disc (CD) containing a plurality of birdsongs associated with respective ones of the plurality of birds, each of the plurality of birdsongs being individually addressable by means of a unique index associated therewith. There is also a CD player for playing the CD to output digital data streams reflecting selected ones of the birdsongs as well as a headset or speaker connected to the Compact Disc player means for reproducing birdsongs from the digital data streams. A data compression technique is employed which permits the system to be used for " talking book" applications with as much as nine hours of playing from a single CD. An interactive audio system configuration of the invention is also shown which can improve language learning and provide an environment for interactive audio adventures.
Patent AU-7955787-A (AU)
Title: Dental material for the control of caries and paradentitis
Inventor: MICHL RUDOLF J
IPC: A61K6/00
Filed: 1987-10-12
Abstract: The material contains a combination of the active substances thymol and/or carvacrol and chlorhexidine and/or the physiologically tolerated salts thereof. The material can be a dental lacquer or cement or the like which remains for a lengthy period in the oral cavity and out of which the combination of active substances can diffuse.
Patent AU-8290098-A (AU)
Title: Anti-reflective films
Inventor: MCCURDY RICHARD J
IPC: B32B7/02
Filed: 1998-07-06
Abstract: An anti-reflective glass article including a glass substrate, a first coating of a metal oxide and a second coating of a metal oxide. The first coating of metal oxide is applied over the substrate. The refractive index of the first coating of metal oxide ranges from 1.8 to 2.6. The thickness of the first coating is greater than l/(4*n), wherein l equals a design wavelength in the visible spectrum and n equals the refractive index of said first coating of metal oxide. The second coating of metal oxide is applied over the first coating. The second coating of metal oxide has a refractive index of about 1.45 to about 1.6 and a thickness of less than l/4(n).